Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 7.2T | 7.5T | 7.1T | 7.2T |
Cost of revenue | 5.0T | 5.2T | 4.8T | 5.0T |
Gross profit | 2.3T | 2.3T | 2.2T | 2.2T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 874.9B | 914.6B | 861.0B | 877.8B |
Other operating expenses | 95.8B | 87.4B | 174.6B | 83.9B |
Operating income | -89.4B | 111.7B | -34.6B | 47.1B |
Non operating interest income | ||||
Income | 34.8B | 34.1B | 28.5B | 30.9B |
Expense | 124.9B | 125.9B | 123.4B | 119.6B |
Other income expense | — | — | — | — |
Pretax income | -622.5B | 117.9B | -133.7B | 32.9B |
Tax provision | -26.2B | 12.5B | -21.8B | 3.5B |
Net income | -596.3B | 105.4B | -111.9B | 29.4B |
Basic EPS | — | 4.5K | -5.5K | 893 |
Diluted EPS | — | 4.5K | -5.5K | 893 |
Basic average shares | — | 26.8M | 26.4M | — |
Diluted average shares | — | 26.8M | 26.4M | — |
EBITDA | 227.6B | 656.6B | 349.6B | 539.7B |
Net income from continuing op. | -622.5B | 117.9B | -133.7B | 32.9B |
Minority interests | 4.6B | 15.2B | -34.6B | -1.9B |
Preferred stock dividends | — | — | — | — |